IP Library Assignment 043259/0434
Patent Assignment
Reel/Frame 043259/0434

Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 35923/0749

Recorded: 2017-07-19 Pages: 8
Assignor
IMMY FUNDING LLC
Executed: 2017-06-19
Assignee
IMPRIMIS PHARMACEUTICALS, INC.
12264 EL CAMINO REAL, SUITE 350, SAN DIEGO, CALIFORNIA, 92130
Covered Properties (31)
Anti-Cellulite Composition and Method of Treating Cellulite
Pharmaceutical Compositions for Intraocular Administration and Methods for Fabricating Thereof
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Pharmaceutical Formulations of Tranexamic Acid and Their Use
Intraocular Lens Comprising Pharmaceutical Compositions and Methods for Fabricating Thereof
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricatiing Thereof
Transdermal Delivery of Medications Using a Combination of Penetration Enhancers
Patent: 5,837,289 →
Application: 08/685,172 →
Novel Interstitial Therapy for Immediate Symptom Relief and Chronic Therapy in Interstitial Cystitis
Patent: 7,414,039 →
Application: 11/045,411 →
Publication: US 2005/0234013
Novel Interstitial Therapy for Immediate Symptom Relief and Chronic Therapy in Interstitial Cystitis
Patent: 9,486,474 →
Application: 12/188,134 →
Publication: US 2008/0300219
Method and Apparatus for Self-Dosing and Self-Administering Pharmaceutical Compositions
Application: 13/592,300 →
Publication: US 2014/0058339
Anti-Cellulite Composition and Method of Treating Cellulite
Application: 13/703,496 →
Publication: US 2013/0210840
Pharmaceutical Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/227,819 →
Publication: US 2015/0024996
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Patent: 9,849,133 →
Application: 14/307,773 →
Publication: US 2015/0017151
Pharmaceutical Formulations of Tranexamic Acid and Their Use
Patent: 9,301,936 →
Application: 14/325,630 →
Publication: US 2015/0038406
Intraocular Lens Comprising Pharmaceutical Compositions and Methods for Fabricating Thereof
Application: 14/458,049 →
Publication: US 2016/0045432
Pharmaceutical Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/461,242 →
Publication: US 2015/0025511
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/506,120 →
Publication: US 2015/0119440
Pharmaceutical Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/596,865 →
Publication: US 2015/0129457
Pharmaceutical Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/629,173 →
Publication: US 2015/0164882
Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
Application: 60/540,186 →
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Application: 61/836,535 →
Pharmaceutical Formulations of Tranexamic Acid, and Their Use
Application: 61/843,705 →
Epinephrine Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 61/886,269 →
Epinephrine-Based Compositions and Methods for Fabricating Thereof
Application: 61/892,872 →
Pharmaceutical Formulations of Tranexamic Acid and Their Use
Application: 61/917,071 →
Epinephrine Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 61/947,778 →
Pharmaceutical Formulations of Tranexamic Acid and Their Use
Application: 61/951,916 →
Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
Application: 61/958,170 →
Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof
Application: 62/002,711 →
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives
Application: 62/100,368 →
Pharmaceutical Formulations for Treating Male Sexual Dysfunctions
Application: 62/154,027 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 21, 2012
From: BAUM, MARK L.; SCHUPP, JOACHIM P.H.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 028999/0981 →
Change of Name Dec 7, 2012
From: TRANSDEL PHARMACEUTICALS, INC.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 029425/0508 →
Assignment of Assignor's Interest Aug 28, 2013
From: BUDERER, MATTHEW J.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031101/0977 →
Change of Name Aug 28, 2013
From: TRANSDEL PHARMACEUTICALS, INC.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031106/0472 →
Release of Security Interest Aug 28, 2013
From: IMPRIMIS PHARMACEUTICALS, INC.
To: DERMASTAR INTERNATIONAL, LLC
Reel/Frame 031103/0201 →
Assignment of Assignor's Interest Aug 28, 2013
From: BUDERER, MATTHEW JAMES
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031102/0570 →
Assignment of Assignor's Interest Sep 3, 2013
From: COVALESKY, BERNARD
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031126/0298 →
Assignment of Assignor's Interest Sep 3, 2013
From: PETERS, KALLAN
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031126/0465 →
Assignment of Assignor's Interest Sep 3, 2013
From: KAROLCHYK, JOHN SCOTT
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031126/0436 →
Assignment of Assignor's Interest Sep 3, 2013
From: DILZER, RICHARD
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031126/0387 →
Assignment of Assignor's Interest Sep 26, 2013
From: LIEGNER, JEFFREY T.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031291/0946 →
Assignment of Assignor's Interest Oct 9, 2013
From: KAROLCHYK, JOHN SCOTT
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031372/0628 →
Assignment of Assignor's Interest Oct 23, 2013
From: KAROLCHYK, JOHN SCOTT; BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031459/0109 →
Assignment of Assignor's Interest Nov 27, 2013
From: GRASELA, JOSEPH; SCHUPP, JOACHIM; NACHT, SERGIO
To: TRANSDEL PHARMACEUTICALS, INC.
Reel/Frame 031686/0094 →
Change of Name Nov 27, 2013
From: TRANSDEL PHARMACEUTICALS, INC.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 031686/0340 →
Assignment of Assignor's Interest Mar 18, 2014
From: BUDERER, MATTHEW JAMES
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 032459/0665 →
Assignment of Assignor's Interest Jun 4, 2014
From: BUDERER, MATTHEW JAMES; ABRAMS, JEFFREY JOEL
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033027/0450 →
Assignment of Assignor's Interest Jul 7, 2014
From: KAROLCHYK, JOHN SCOTT
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033249/0773 →
Assignment of Assignor's Interest Jul 15, 2014
From: LIEGNER, JEFFREY T.; KAROLCHYK, JOHN SCOTT; DILZER, RICHARD; PETERS, KALLAN
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033313/0543 →
Assignment of Assignor's Interest Aug 28, 2014
From: BUDERER, MATTHEW J.; ABRAMS, JEFFREY J.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033630/0620 →
Assignment of Assignor's Interest Aug 28, 2014
From: BUDERER, MATTHEW J.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033630/0592 →
Assignment of Assignor's Interest Oct 24, 2014
From: KAROLCHYK, JOHN SCOTT; BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 034025/0070 →
Assignment of Assignor's Interest Dec 15, 2014
From: SEELHORST, GARY; HARVEY, THOMAS; BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 034511/0255 →
Assignment of Assignor's Interest Dec 16, 2014
From: WILEY, WILLIAM F.; DILZER, RICHARD
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 034520/0925 →
Assignment of Assignor's Interest Mar 13, 2015
From: COVALESKY, BERNARD
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 035162/0070 →